The antiphospholipid antibodies present in antiphospholipid syndrome (APS) are directed at
a number of phospholipid-binding proteins: β2 glycoprotein I (β2GPI), prothrombin, and so …

Among the diagnostic assays for anti-phospholipid syndrome (APS), lupus anticoagulant
(LA) is the strongest predictor of thrombosis; however, it presents several limitations as …

Antiprothrombin antibodies, measured with phosphatidylserine/prothrombin complex
(aPS/PT) ELISA, have been reported to be associated with antiphospholipid syndrome …

Objective The clinical significance of anti-phosphatidylserine/prothrombin (aPS/PT) in
antiphospholipid syndrome (APS) is still controversial. We assessed the prevalence of …

Antibodies to prothrombin are detected by directly coating prothrombin on irradiated ELISA
plates (aPT) or by using the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …

Background: Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be
considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study …

Background: Antiphosphatidylserine/prothrombin complex (aPS/PT) antibodies are
emerging as an important marker for antiphospholipid syndrome (APS). We aimed to …

According to the preliminary classification criteria of the antiphospholipid syndrome
(APS)(Sapporo Criteria), β2-glycoprotein I (β2GPI)-dependent anticardiolipin antibodies …

Background: The aim of the study was to determine the prevalence and clinical associations
of antiphosphatidylserine/prothrombin antibodies (aPS/PT) with thrombosis and pregnancy …

Objective The aim of the study is to perform a systematic review on the recent available
evidence on antiphosphatidylserine/prothrombin (aPS/PT) antibodies and their association …